CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...
Phase 3
Budapest, Hungary and 52 other locations
12 years old with moderate to severe asthma....
Phase 2
Budapest, Hungary and 22 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Budapest, Hungary and 62 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Százhalombatta, Hungary and 69 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Gödöllő, Pest County, Hungary and 131 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Budapest, Hungary and 74 other locations
This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an exis....
Phase 2
Monor, Hungary and 166 other locations
This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...
Phase 2
Gödöllő, Hungary and 238 other locations
inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma...
Phase 2
Székesfehérvár, Hungary and 38 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Budapest, Hungary and 394 other locations
Clinical trials
Research sites
Resources
Legal